Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
October 16, 2024 07:00 ET
|
Nodenza Venture Partners
Nodenza Venture Partners launched Focus on international early-stage and pre-commercial biotech & medtech opportunities New York, October 16, 2024 – Nodenza Venture Partners (“Nodenza”) has been...
Forbion raises in excess of €2 billion for two new funds
October 15, 2024 01:00 ET
|
Forbion
Forbion’s largest fundraising to date with Forbion’s Growth Opportunities Fund III raising €1.2 billion & Forbion Ventures Fund VII raising €890 million
Kneat Announces Closing of $35.6 Million Bought Deal
October 10, 2024 10:17 ET
|
kneat.com, inc.
Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million.
Curia Commits to SBTi Net-Zero Standard
October 08, 2024 09:00 ET
|
Curia Global, Inc.
Curia today announced its commitment to set near- and long-term greenhouse gas reductions in line with the Science Based Targets initiative (SBTi).
Sai Life Sciences releases Sustainability Report 2024
October 07, 2024 05:03 ET
|
SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its...
Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
September 25, 2024 08:16 ET
|
Spherix Global Insights
EXTON, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm, is expanding its specialized offerings to buy-side financial firms...
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
September 25, 2024 07:30 ET
|
Acasti Pharma, Inc.
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of...
YPrime Recognized as Trailblazer in Patient Engagement by Everest Group
September 24, 2024 08:42 ET
|
Y-Prime, LLC
YPrime has been recognized as a Trailblazer in patient engagement by Everest Group for its innovative solutions that enhance clinical trial participation.
Noom Calls for Affordable Choices and Fair Pricing of Weight-Loss Medications Ahead of Tuesday’s Senate Testimony
September 24, 2024 07:02 ET
|
Noom Inc
Noom issued a call for public support of a new petition demanding affordable choices and fair pricing for GLP-1 weight-loss medications.
KFSHRC Celebrates Landmark Contributions at 2024 NYC C3 Summit Davos of Healthcare
September 18, 2024 06:00 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Celebrates Landmark Contributions at 2024 NYC C3 Summit Davos of Healthcare